T1	PROC 45 76	Estudio de seguridad y eficacia
T2	CHEM 136 145	Nivolumab
#1	AnnotatorNotes T2	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	CHEM 150 160	Ipilimumab
#2	AnnotatorNotes T3	C1367202; ipilimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	DISO 176 184	melanoma
#3	AnnotatorNotes T4	C0025202; melanoma; Neoplastic Process
T5	PROC 207 238	Estudio fase IIIb, aleatorizado
T6	CHEM 299 308	Nivolumab
#4	AnnotatorNotes T6	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T7	CHEM 313 323	Ipilimumab
#5	AnnotatorNotes T7	C1367202; ipilimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T8	DISO 339 347	melanoma
#6	AnnotatorNotes T8	C0025202; melanoma; Neoplastic Process
T9	DISO 419 427	Melanoma
#7	AnnotatorNotes T9	C0025202; melanoma; Neoplastic Process
T10	DISO 464 472	melanoma
#8	AnnotatorNotes T10	C0025202; melanoma; Neoplastic Process
T11	DISO 725 733	melanoma
#9	AnnotatorNotes T11	C0025202; melanoma; Neoplastic Process
T12	PROC 377 384	tratado
#10	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T13	PROC 927 949	tratamiento oncológico
T14	DISO 972 980	melanoma
#11	AnnotatorNotes T14	C0025202; melanoma; Neoplastic Process
T15	DISO 1047 1068	metástasis cerebrales
#12	AnnotatorNotes T15	C0220650; Metastatic malignant neoplasm to brain; Neoplastic Process | C0555278; Cerebral metastasis; Neoplastic Process
T16	DISO 1079 1104	metástasis leptomeníngeas
#13	AnnotatorNotes T16	C1704231; Metastatic Malignant Neoplasm to the Leptomeninges; Neoplastic Process
T17	DISO 1120 1135	melanoma ocular
#14	AnnotatorNotes T17	C0558356; Malignant melanoma of eye; Neoplastic Process
T18	DISO 1150 1171	enfermedad autoinmune
#15	AnnotatorNotes T18	C0004364; Autoimmune Diseases; Disease or Syndrome
T19	PROC 90 117	regímenes de administración
T20	PROC 253 280	regímenes de administración
T21	DISO 362 373	metastásico
#16	AnnotatorNotes T21	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T22	DISO 487 498	metastásico
#17	AnnotatorNotes T22	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T23	DISO 748 759	metastásico
#18	AnnotatorNotes T23	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T24	PROC 502 509	tratado
#19	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	DISO 995 1006	metastásico
#20	AnnotatorNotes T25	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T26	ANAT 1058 1068	cerebrales
#21	AnnotatorNotes T26	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T27	ANAT 1090 1104	leptomeníngeas
#22	AnnotatorNotes T27	C0228126; Leptomeninges; Body Part, Organ, or Organ Component | C1284563; Entire leptomeninges; Body Part, Organ, or Organ Component
T28	ANAT 1129 1135	ocular
#23	AnnotatorNotes T28	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T29	Date 13 17	2016
T30	LIVB 164 171	sujetos
#24	AnnotatorNotes T30	C0681850; Study Subject; Group
T31	LIVB 327 334	sujetos
#25	AnnotatorNotes T31	C0681850; Study Subject; Group
T32	Neg_cue 374 376	no
T33	LIVB 452 459	Sujetos
#26	AnnotatorNotes T33	C0681850; Study Subject; Group
T34	Neg_cue 499 501	no
T35	LIVB 549 556	Hombres
#27	AnnotatorNotes T35	C0025266; Male population group; Population Group
T36	LIVB 559 566	mujeres
#28	AnnotatorNotes T36	C0043210; Woman; Population Group
T37	Age 575 585	>= 15 años
T40	LIVB 677 684	sujetos
#29	AnnotatorNotes T40	C0681850; Study Subject; Group
T41	Age 685 694	< 18 años
T42	LIVB 705 712	sujetos
#30	AnnotatorNotes T42	C0681850; Study Subject; Group
T45	LIVB 883 892	Pacientes
#31	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T47	Neg_cue 920 926	ningún
T48	LIVB 1035 1042	Sujetos
#32	AnnotatorNotes T48	C0681850; Study Subject; Group
T49	LIVB 1108 1115	Sujetos
#33	AnnotatorNotes T49	C0681850; Study Subject; Group
T50	LIVB 1138 1145	Sujetos
#34	AnnotatorNotes T50	C0681850; Study Subject; Group
T51	Spec_cue 1191 1201	sospechada
T38	PROC 811 827	Estado funcional
#35	AnnotatorNotes T38	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T39	PROC 781 797	histológicamente
#36	AnnotatorNotes T39	C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T12 Negated
A2	Assertion T24 Negated
A5	Assertion T13 Negated
A6	Assertion T18 Speculated
A3	Status T18 History_of
A4	Status T13 History_of
A7	Status T12 History_of
A8	Status T24 History_of
#37	AnnotatorNotes T1	C0511730; Identify product efficacy and safety issues; Health Care Activity
#38	AnnotatorNotes T5	C1706097; Trial Phase 3B; Research Activity + C0034656; Randomization; Research Activity
T43	Neg_cue 650 652	no
T44	Observation 653 676	permitan que participen
A9	Assertion T44 Negated
#39	AnnotatorNotes T44	C1302261; Patient eligible for clinical trial; Finding (?)
A10	Assertion T40 Negated
A11	Assertion T41 Negated
R1	Combined_with Arg1:T2 Arg2:T3	
R2	Experiences Arg1:T30 Arg2:T4	
R3	Experiences Arg1:T30 Arg2:T2	
R4	Combined_with Arg1:T6 Arg2:T7	
T46	Quantifier_or_Qualifier 80 89	múltiples
#40	AnnotatorNotes T46	C0439064; Numerous; Quantitative Concept
R5	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T46	
T52	Quantifier_or_Qualifier 243 252	múltiples
#41	AnnotatorNotes T52	C0439064; Numerous; Quantitative Concept
R6	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T52	
R7	Experiences Arg1:T31 Arg2:T6	
R8	Experiences Arg1:T31 Arg2:T8	
R9	Experiences Arg1:T31 Arg2:T21	
R10	Before Arg1:T8 Arg2:T21	
R11	Experiences Arg1:T31 Arg2:T12	
T53	Observation 473 484	irresecable
#42	AnnotatorNotes T53	C4039777; Tumor surgically unresectable; Finding
R12	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T53	
T54	Observation 348 359	irresecable
#43	AnnotatorNotes T54	C4039777; Tumor surgically unresectable; Finding
R13	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T54	
R14	Before Arg1:T10 Arg2:T22	
R15	Experiences Arg1:T33 Arg2:T10	
R17	Experiences Arg1:T33 Arg2:T22	
R19	Experiences Arg1:T33 Arg2:T24	
R20	Has_Age Arg1:T36 Arg2:T37	
R21	Has_Age Arg1:T35 Arg2:T37	
R22	Negation Arg1:T43 Arg2:T44	
R24	Has_Age Arg1:T40 Arg2:T41	
R25	Experiences Arg1:T42 Arg2:T11	
R26	Experiences Arg1:T42 Arg2:T23	
T55	Quantifier_or_Qualifier 764 780	estadio III o IV
R27	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T55	
T56	Observation 734 745	irresecable
#44	AnnotatorNotes T56	C4039777; Tumor surgically unresectable; Finding
R29	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T56	
R31	Before Arg1:T11 Arg2:T23	
R33	Experiences Arg1:T42 Arg2:T39	
T57	CONC 832 866	Eastern Cooperative Oncology Group
#45	AnnotatorNotes T57	C1520224; ECOG performance status; Intellectual Product
T58	CONC 868 872	ECOG
#46	AnnotatorNotes T58	C1520224; ECOG performance status; Intellectual Product
T59	Result_or_Value 877 880	0-1
R34	Has_Result_or_Value Arg1:T58 Arg2:T59	
R35	Has_Result_or_Value Arg1:T57 Arg2:T59	
R36	Used_for Arg1:T57 Arg2:T38	
R37	Used_for Arg1:T58 Arg2:T38	
R38	Negation Arg1:T47 Arg2:T13	
R39	Experiences Arg1:T45 Arg2:T13	
R40	Experiences Arg1:T45 Arg2:T14	
R41	Experiences Arg1:T45 Arg2:T25	
T60	Observation 981 992	irresecable
R42	Before Arg1:T14 Arg2:T25	
R43	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T60	
#47	AnnotatorNotes T60	C4039777; Tumor surgically unresectable; Finding
R45	Location_of Arg1:T26 Arg2:T15	
R46	Location_of Arg1:T27 Arg2:T16	
R47	Location_of Arg1:T28 Arg2:T17	
R48	Experiences Arg1:T48 Arg2:T15	
R49	Experiences Arg1:T48 Arg2:T16	
R50	Experiences Arg1:T49 Arg2:T17	
R51	Experiences Arg1:T50 Arg2:T18	
R52	Speculation Arg1:T51 Arg2:T18	
T61	Quantifier_or_Qualifier 1172 1178	activa
#48	AnnotatorNotes T61	C0679217; Active State; Idea or Concept
T62	Quantifier_or_Qualifier 1069 1076	activas
#49	AnnotatorNotes T62	C0679217; Active State; Idea or Concept
R53	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T62	
R54	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T61	
R16	Negation Arg1:T34 Arg2:T24	
R18	Negation Arg1:T32 Arg2:T12	
R23	Overlap Arg1:T44 Arg2:T41	
#50	AnnotatorNotes T13	C0920425; cancer treatment; Therapeutic or Preventive Procedure
T63	Quantifier_or_Qualifier 950 959	sistémico
A12	Assertion T63 Negated
#51	AnnotatorNotes T63	C0205373; Systemic; Functional Concept
R28	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T63	
R30	Negation Arg1:T47 Arg2:T63	
A13	Experiencer T30 Patient
A14	Experiencer T31 Patient
A15	Experiencer T33 Patient
A16	Experiencer T35 Patient
A17	Experiencer T36 Patient
A18	Experiencer T42 Patient
A19	Experiencer T45 Patient
A20	Experiencer T48 Patient
A21	Experiencer T49 Patient
A22	Experiencer T50 Patient
